Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
174
datasets available to search
ShareScore release 0.9.0
Dataset results
174 results for “Neurofibromatosis I”
Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia
ClinicalTrials.gov study NCT07088991. IPD Sharing: YES. Countries: 1. Publications: 0.
Intervention Effectiveness on the Neurocognitive Functioning of Children and Adolescents With Neurofibromatosis Type 1
ClinicalTrials.gov study NCT05377008. IPD Sharing: NO. Countries: 1. Publications: 0.
Neurofibromatosis (NF) Registry Portal
ClinicalTrials.gov study NCT01885767. IPD Sharing: NO. Countries: 1. Publications: 0.
Neurofibromatosis Type 1 Brain Tumor Genetic Risk
ClinicalTrials.gov study NCT01707836. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
ClinicalTrials.gov study NCT02544022. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1
ClinicalTrials.gov study NCT05199376. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neu
ClinicalTrials.gov study NCT02390752. IPD Sharing: YES. Countries: 1. Publications: 0.
Reliability of Functional Outcome Measures in Neurofibromatosis 1: Test- Retest
ClinicalTrials.gov study NCT05186870. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis
ClinicalTrials.gov study NCT05107037. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.
ClinicalTrials.gov study NCT02078401. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dosing and Tolerability of Deoxycholic Acid vs. Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas
ClinicalTrials.gov study NCT06120036. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas
ClinicalTrials.gov study NCT06132165. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1
ClinicalTrials.gov study NCT05677594. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1
ClinicalTrials.gov study NCT07024394. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Reliability of Functional Outcome Measures in Neurofibromatosis 2
ClinicalTrials.gov study NCT03617276. IPD Sharing: NO. Countries: 1. Publications: 0.
How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem
ClinicalTrials.gov study NCT01626846. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype
ClinicalTrials.gov study NCT02387177. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1
ClinicalTrials.gov study NCT00865644. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas
ClinicalTrials.gov study NCT02177825. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neurofibromatosis Type 1 Patient Registry
ClinicalTrials.gov study NCT01410006. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.